| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 2,458.0 | 2,618.0 |
| Profit before tax | -589.0 | -370.0 |
| Net income | -570.0 | -320.0 |
| EPS (diluted, $ a share) | $-0.85 | $-0.47 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -6.1% |
|---|
10-Q filed with the SEC, NYSE: CTVA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Corteva, Inc.: key numbers
- Share price
- $9.04Close, Nov 16
- Market cap
- $6.03B
- Shares outstanding
- 667.32MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Agricultural Production-CropsSIC 0100
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Corteva, Inc.
All →Corteva Director Gregory R. Page Buys $185K of Stock
Gregory R. Page, Director, bought 20,000 shares of Corteva, Inc. at $9.25 to $9.29 a share (average $9.27) in 2 transactions, worth $185K in total between Nov 13, 2026 and Nov 16, 2026. Shares held after the trade: 20,000 (+100.0%).
- Value
- $185K
- Shares
- 20,000
- Average price
- $9.27
- Role
- Director
- Holding change
- +100.0%
- Trade date
- Nov 13, 2026 to Nov 16, 2026
Corteva CEO Luther C. Kissam IV Buys $300K of Stock
Luther C. Kissam IV, CEO, bought 32,292 shares of Corteva, Inc. at $9.30 a share, worth $300K in total on Nov 13, 2026. Shares held after the trade: 185,379 (+21.1%).
- Value
- $300K
- Shares
- 32,292
- Price
- $9.30
- Role
- CEO
- Holding change
- +21.1%
- Trade date
- Nov 13, 2026
Corteva Financial Results
Corteva, Inc. filed combined financial statements for 'New Corteva' (its Crop Protection Business) following the October 1, 2026, spin-off of its Seed Business into Vylor Inc. The filing provides historical and interim financial results for the three and nine months ended September 30, 2026, reflecting the new corporate structure where Vylor is treated as the accounting successor.
- Term
- Q3 2026
Corteva Financial Results
Corteva reported third-quarter 2026 financial results, with net sales of $1.59 billion, a 9% decrease compared to the prior year. The company updated its full-year 2026 guidance, lowering expectations due to weaker market conditions in Brazil and pricing pressure on older molecules.
“We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based organic growth outside Latin America. The pressure remains concentrated. Acetochlor pricing in the U.S. was consistent with our expectations, but Brazil was materially weaker than anticipated. While those conditions are reflected in our updated outlook, our strategy has not changed. Innovation, productivity and disciplined execution remain the foundation for sustainable long-term growth.”
Luke Kissam, CEO
Corteva Court & Legal Update
Corteva and its subsidiary EIDP are facing litigation from 15 states challenging the separation of Corteva and Vylor into independent companies. A District Court issued a temporary restraining order (TRO) enjoining the company from paying dividends, repurchasing shares, or disposing of assets outside the ordinary course of business, though the order has been stayed pending an emergency appeal to the Seventh Circuit. Corteva intends to vigorously defend against the claims and contests the legal and factual bases for the relief sought.
- Counterparty
- 15 states and one sovereign
Corteva Leadership Change
In connection with the spin-off of its seed segment into Vylor Inc., Corteva completed a major leadership transition including the appointment of Luther Kissam as CEO and Jeff Rudolph as CFO. Additionally, four directors resigned from the board, including former CEO Charles V. Magro, while the board committees were reconstituted under the new leadership structure.